HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection

Bravo MJ, Vallejo F, Barrio G, Brugal MT, Molist G, Pulido J, et al. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection. Int J Drug Policy. 2012;23(5):415-419.

Publication Type:

Journal Article

Authors:

Bravo, M.J.; Vallejo, F.; Barrio, G.; Brugal, M.T.; Molist, G.; Pulido, J.; Sordo, L.; de la Fuente, L.; ITINERE project group

Source:

Int J Drug Policy, Volume 23, Issue 5, p.415-419 (2012)

Keywords:

Adolescent, Adult, Aged, Cities, Cohort Studies, complications, Data Collection, Drug Users, epidemiology, etiology, Female, Follow-Up Studies, Harm Reduction, HCV, Health, hepatitis, Hepatitis C, hepatitis C virus, Heroin, Heroin Dependence, Humans, immunology, Incidence, Infection, Interviews, Male, methods, Multivariate Analysis, Poisson Distribution, Prospective Studies, Public Health, Research, Research Support, Risk, Spain, Substance Abuse,Intravenous, Time, Young Adult

Cited On:

HCV Testing and Linkage to Care

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/22421554

Export Citation:

RIS Format

Top